OR WAIT null SECS
Pharma event announces plans to alternate locations between Indonesia and Thailand to open new market opportunities.
CPhI South East Asia announced that, starting in 2019, the event will alternate its annual location between Indonesia and Thailand. The move to Thailand is designed to strengthen the event’s appeal within the region and attract new visitors from more diverse locations, the organizers said in an April 9, 2018 press statement.
In 2019, CPhI South East Asia will take place at the Queen Sirikit National Convention Center (QSNCC) in Bangkok, Thailand on March 12–14; for 2020, the event will return to Jakarta International Expo (JIExpo) in Indonesia on March 4–6.
CPhI South East Asia will co-locate in 2019 with FDF, ICSE, P-MEC, InnoPack, and LABworld South East Asia. UBM forecasts the inaugural edition in Bangkok will host more than 6000 attendees and 270 exhibitors. Attendees will include pharma ingredients professionals, packaging experts, machinery providers, contract manufacturers, nutraceutical companies, and laboratory specialists.
“This is very much a natural progression for CPhI South East Asia and the region, opening even greater opportunities to meet new partners and expand pharma sales. Collectively, these two countries account for over 50% of the region’s sales,” said Chris Kilbee, group director, Pharma at UBM. “Our research shows there is large opportunity, in particular, for contract services and ingredients, and by annually switching location we will increase the depth and quality of regional partners available.”
The event is organized by UBM, which owns BioPharm International.
Source: CPhI South East Asia